Bhat Laxminarayan - 22 Sep 2025 SCHEDULE 13D/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager
Bhat Laxminarayan
Reporting Manager
Bhat Laxminarayan
Security
REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share
Symbol
RVPH
Shares outstanding
96,865,105 shares
Disclosed Ownership
3,680,874 shares
Ownership
3.8%
Form type
SCHEDULE 13D/A
Filing time
24 Sep 2025, 16:33:30 UTC
Date of event
22 Sep 2025
Previous filing
01 Jul 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Bhat Laxminarayan disclosed 3.8% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH) on 22 Sep 2025."

Quick Takeaways

  • Bhat Laxminarayan filed SCHEDULE 13D/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH).
  • Disclosed ownership: 3.8%.
  • Date of event: 22 Sep 2025.

What Changed

  • Previous schedule filing date: 01 Jul 2025.
  • Current filing was accepted on 24 Sep 2025, 16:33.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bhat Laxminarayan 3.8% 3,680,874 3,352,177 328,697 /s/ Laxminarayan Bhat Laxminarayan Bhat 0001818245

Sponsored